8-K: 180 Life Sciences (ETHZilla) Holds 82,186 ETH

180 Life Sciences Corp., dba ETHZilla, announced it holds 82,186 ETH with an average acquisition price of $3,806.71, valued at approximately $349 million.

Summary

• 180 Life Sciences Corp. (ETHZilla) has acquired 82,186 ETH at an average price of $3,806.71, now valued at approximately $349 million as of August 11, 2025.
• The company also holds approximately $238 million in USD cash equivalents.
• The ETH purchases were funded by proceeds from a previously disclosed private PIPE offering and sale of convertible notes.
• The company plans to rebrand as ETHZilla Corporation and aims to become a benchmark for on-chain treasury management.
• The company intends to monetize its existing biotech assets and continue developing its gaming initiatives.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the company's successful accumulation of ETH and its plans to generate yield. However, risks associated with cryptocurrency investments temper the overall sentiment.

Positives

• ETHZilla holds 82,186 ETH valued at approximately $349 million.
• The company has $238 million in USD cash equivalents.
• The company has put over $350 million in capital to work since the PIPE transaction.
• The company plans to generate yield through its on-chain yield generation program with Electric Capital.
• The company is supported by an executive team and DeFi Council.

Negatives

• The company's stock price may be highly correlated to the price of the digital assets that it holds.
• The company is subject to risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally.
• The company is subject to risks relating to the treatment of crypto assets for U.S. and foreign tax purpose.
• The company is subject to risks relating to its outstanding convertible notes, including the Companys ability to repay such notes, covenants associated therewith and dilution caused by the conversion thereof into common stock, and security interests associated therewith.

Risks

• The proposed transactions may not be completed in a timely manner or at all.
• Failure to realize the anticipated benefits of the PIPE, convertible notes, and related transactions, including the Companys recent digital asset treasury strategy.
• The Companys ability to achieve profitable operations.
• Fluctuations in the market price of ETH will impact the Companys accounting and financial reporting.
• Government regulation of cryptocurrencies and online betting.
• Changes in securities laws or regulations.
• Risks relating to the Companys outstanding convertible notes, including the Companys ability to repay such notes, covenants associated therewith and dilution caused by the conversion thereof into common stock, and security interests associated therewith.
• Risks relating to the Companys operations and business, including the highly volatile nature of the price of Ether and other cryptocurrencies.
• The risk that the Companys stock price may be highly correlated to the price of the digital assets that it holds.
• Risks related to increased competition in the industries in which the Company does and will operate.
• Risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally.
• Risks relating to the treatment of crypto assets for U.S. and foreign tax purpose.
• Potential litigation involving the Company or the validity or enforceability of the intellectual property of the Company.
• Global economic conditions, geopolitical events and regulatory changes.
• Access to additional financing, and the potential lack of such financing.
• The Companys ability to raise funding in the future and the terms of such funding, including dilution caused thereby.

Future Outlook

The company plans to continue providing updates on its treasury and on-chain yield generation strategies through public releases and regulatory filings. It also intends to monetize its existing biotech assets and continue developing its gaming initiatives. The company expects the most recently purchased ETH to be held long-term and staked to Electric Capitals own proprietary Ethereum network strategies to generate yield.

Management Comments

• McAndrew Rudisill, Executive Chairman of the Company: We have put over $350 million in capital to work since the PIPE transaction we completed last week, and have executed on our strategy to rapidly build a differentiated Ethereum treasury vehicle.
• McAndrew Rudisill, Executive Chairman of the Company: We believe that this reserve of ETH will unlock cash flow for our shareholders as we seek to deliver on our on-chain yield generation program through our external asset manager Electric Capital.

Industry Context

This announcement reflects a growing trend of companies, particularly those in the technology and gaming sectors, exploring digital asset treasury strategies. The move to accumulate ETH and generate yield through staking and DeFi protocols aligns with the broader adoption of blockchain technology and cryptocurrencies in corporate finance.

Comparison to Industry Standards

• MicroStrategy: Known for holding a significant amount of Bitcoin on its balance sheet, serving as a benchmark for corporate crypto adoption.
• Tesla: Briefly held Bitcoin, demonstrating the potential for large corporations to allocate capital to cryptocurrencies.
• Other companies exploring digital asset strategies: Square (Block), Coinbase, and various DeFi-native organizations.

Stakeholder Impact

• Shareholders: Potential for increased cash flow and returns through ETH yield generation.
• Employees: Potential for growth and innovation in the company's new strategic direction.
• Customers: Potential for new gaming and entertainment offerings.
• Investors: Potential for increased stock price due to the company's ETH holdings and yield generation strategy.

Next Steps

• Continue to provide updates to its Treasury and on chain yield generation strategies, through public releases and regulatory filing(s), as available.
• The Company plans to rebrand as ETHZilla Corporation.
• The Company will continue to maintain and accelerate the deployment and development of its gaming initiatives.

Key Dates

Recommendation

The company has successfully deployed capital from its PIPE transaction into ETH and has a plan to generate yield from its ETH holdings. The company also has a significant amount of USD cash equivalents. This makes the stock a buy.

Keywords

ETHZilla, 180 Life Sciences, ETH, Ethereum, Cryptocurrency, Treasury Management, DeFi, Digital Assets, PIPE Offering, Convertible Notes